• Medico-scientific in depth analysis of competitors’ forms by region (EU-US- Japon – RoW)
• Gap analysis of patients’ unmet needs or inadequacy of existing treatments
• IP analysis – Freedom of Exploitation
• CMC Target Product Profile
• Review/elaboration of Development – Co-Development – Acquisition (in-licensing) scenarios